Skip to content

Valid-B.Well BP25 Study

Validation of the B. Well Digital Upper Arm Blood Pressure Monitor Pro-25 According to ISO 81060- 2

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07340957
Enrollment
100
Registered
2026-01-14
Start date
2026-01-31
Completion date
2026-03-31
Last updated
2026-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Study Focus: Blood Pressure Measures, Volunteers

Keywords

blood pressure, iso 81060-2, upper arm blood pressure monitor, commercialized device validation

Brief summary

Prospective, single-center, single-arm, open, comparative, validation of a commercialized device, repeated measures accuracy study designed in accordance with the requirements of the ISO 81060-2:2018 AAMI/ESH/ISO Universal Standard for the clinical validation of automated non-invasive sphygmomanometers (Non-invasive sphygmomano-meters - Part 2: Clinical investigation of intermittent automated measurement, including Amendments 1 and 2)). The validation will be conducted with volunteers rather than necessarily with patients, and all measurements will be performed outside of the subjects' normal diagnosis or treatment.

Interventions

DIAGNOSTIC_TESTBlood pressure measurement

All measurements will be performed by trained observers in line with the requirements of the ISO 81060-2:2018 AAMI/ESH/ISO Universal Standard (1), ensuring accuracy, consistency, and reproducibility. The investigation shall be performed in an isolated room under comfortable ambient temperature. * The cuff shall be applied on the bare arm with no compression proximal to the cuff. * The subject shall rest quietly for at least 10 minutes prior to the start of measurements. * The subject should avoid talking during the entire measurement procedure. * BP shall be measured on the subject's left arm at heart level. * A minimum of 5 minutes shall elapse prior to obtaining the first reference blood pressure measurement.

Sponsors

European Cardiovascular Research Center
CollaboratorNETWORK
B.Well Swiss AG
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Intervention model description

Prospective, single-center, single-arm, open, comparative, validation of a commercialized device, with repeated measures accuracy study designed in accordance with the requirements of the ISO 81060-2:2018 AAMI/ESH/ISO Universal Standard for the clinical validation of automated non-invasive sphygmomanometers (Non-invasive sphygmomano-meters - Part 2: Clinical investigation of intermittent automated measurement, including Amendments 1 and 2)). The study aims to clinically evaluate the accuracy of the B-Well PRO-25 upper arm automated sphygmomanometer for systolic blood pressure (SBP) and diastolic blood pressure (DBP) in adults and adolescents in accordance with ISO 81060-2. The comparative measurements are obtained through auscultation by an observer using a mercury sphygmomanometer (reference method).

Eligibility

Sex/Gender
ALL
Age
12 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age \> 12 years * Signed Informed Consent

Exclusion criteria

* Any medical condition preventing light to moderate arm compression * Absence of the upper arm * Subjects with upper arm circumference \<22 cm or \>42 cm * Subjects with severe shock; * Subjects with a history of mental illness or current mental disorders; * Patients with arrhythmias (atrial premature beats, ventricular premature beats, atrial fibrillation, etc.) or upper limb arteriosclerosis (at the direct measurement site); * Subjects using extracorporeal circulation devices; * Subjects with excessive limb asymmetry; * Subjects who have undergone mastectomy or lymph node dissection; * Subjects with arm injuries or exposed wounds, or those with circulatory disorders; * Subjects with vascular accesses in the arms or arteriovenous shunt tubes; * Subjects who have participated in other clinical trials within the past 1 month; * Subjects for whom the procedures during the clinical trial may pose excessive medical risks; * Subjects determined by the investigator to be unsuitable for participating in the clinical study. * Subject under judicial protection, guardianship or curatorship or participant deprived of their liberty by judicial or administrative decision

Design outcomes

Primary

MeasureTime frameDescription
The study will assess compliance with the following validation criteria defined by the standard ISO 81060-2:2018: Criterion 1 - Group-level accuracy (paired-difference analysis). Criterion 2 - Subject-level accuracyDay 1The study will assess compliance with the following validation criteria defined by the standard ISO 81060-2:2018 for SBP and DBP (in mmHg): Criterion 1 - Group-level accuracy (paired-difference analysis). For systolic blood pressure (SBP) and diastolic blood pressure (DBP) separately, the mean difference between the test device and the reference method (observer auscultation with a mercury sphygmomanometer) across all valid paired determinations shall be within ±5 mmHg, and the standard deviation (SD) of these differences shall be ≤ 8 mmHg. Criterion 2 - Subject-level accuracy For SBP and DBP, each subject's mean difference (test device - reference) shall be calculated from that subject's repeated paired determinations. The standard deviation of these subject-level means across all subjects shall comply with the requirements specified in Table 1 Averaged subject data acceptance in mmHg of ISO 81060-2:2018 (1) for SBP and DBP.

Secondary

MeasureTime frameDescription
Population characteristics- AgeDay 1Age (descriptive summary)
Population Characteristics - Sexday 1Sex (descriptive summaries)
Agreement by Bland-Altman analysisDay 1Calculation of the bias (average difference between test device and reference method) and the 95% limits of agreement (LoA) for systolic blood pressure (SBP) and diastolic blood pressure (DBP), overall and across the blood pressure range
Population Characteristics- baseline blood pressure categoriesDay 1Normotensive/hypertensive ranges for both systolic and diastolic pressures
Observser agreementDay 1percentage of paired measurements (within +/- 4 mmHg)
Population Characteristics- arm circumferencesDay 1arm circumferences (descriptive summaries)

Contacts

Primary ContactThomas Fassler Fassler
thomas.faessler@bwell-swiss.ch+41 79 309 93 79

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026